How the cell and gene therapy market is taking shape
Cell and gene therapy (C>) represents a major advance in medical treatments by directly targeting the root causes of diseases…
Cell and gene therapy (C>) represents a major advance in medical treatments by directly targeting the root causes of diseases…
With the MS Trust estimating that more than 2.9 million people worldwide have multiple sclerosis (MS), new therapies are urgently…
The latest EU clinical trial regulations must be carefully understood. The Clinical Trial Regulation (CTR) was introduced in the EU…
AI and supervised machine learning have considerable benefits for clinical trials. The first episode in this GlobalData-produced series by Zelta…
Leading companies move beyond conventional field planning and embrace dynamic targeting and predictive next-best actions to forge more meaningful relationships…
The pharmaceutical industry is under increasing pressure to transform its manufacturing practices. Traditional processes, often reliant on vast quantities of…
Maintaining efficiency across the supply chain is essential to ensure potentially life-saving pharmaceutical products reach the patients who need them.…
Oligonucleotides (oligos) are short strands of synthetic DNA or RNA that offer huge potential in treatments for a wide range…
A synthetic active pharmaceutical ingredient (API) can offer a crucial option for drug manufacturing. Yet there can be many complexities…
Artificial Intelligence (AI) has the potential to transform healthcare research and development. It has already begun revolutionizing the drug discovery…